Table 1 Monthly average of commercial units of antibiotics sold in Brazil for children aged 1–12 years, between 2014 and 2019 and during the pandemic period (Jan 2020 to July 2021).

From: Impact of COVID-19 on antibiotic prescriptions for Brazilian children

 

2014

2015

2016

2017

2018

2019

Pandemic

Sales Reduction (%)

Amoxicillin

460,879

485,696

514,597

586,303

576,264

603,683

186,655

65.3*

Azithromycin

137,195

149,734

165,952

186,835

188,782

198,973

110,989

35.1*

Cefalexin

101,731

108,492

119,554

116,504

111,688

112,854

73,262

34.4*

SXT

49,747

53,221

53,180

50,007

45,185

45,841

26,990

45.5*

Ceftriaxone

46,871

40,391

31,520

40,286

40,894

43,614

15,667

61.4*

Cefadroxil

13,542

12,943

12,330

11,870

11,063

10,947

5403

55.4*

Metronidazole

20,898

19,611

19,986

17,668

11,313

12,818

8834

48.1*

Levofloxacin

4,414

5,179

6,306

7,249

7376

6750

3990

35.7*

Penicillin G benzathine

2,445

2,908

5,088

3,836

2,644

3460

1847

45.6*

Erythromycin

6,823

5,364

3,856

2,786

225

8

1

99.9*

Total

806,137

883,539

932,369

1,023,344

995,434

1,038,948

433,637

54.1*

  1. *Statistically significant reduction – (P < 0.0001). Dunnett Multiple Comparisons Test. SXT – (sulfamethoxazole and trimethoprim).